[Industry Voice #14] Interview: Addendum ICH E9 (R1) zur ICH E9 Guideline

This episode of Industry Voice highlights a major area of any drug research process. Biostatistics is involved in every step of clinical research including trial design, protocol development, data management and clinical trial reporting. This time our guest is Kristina Bondareva, Head of Biostatistics at OCT Clinical. She will share her thoughts on the role of biostatistics in general, and also comment on the EMA adoption of the E9(R1) addendum on estimands and sensitivity analysis.

To learn more on the topic watch a webinar on the ICH E9(R1) Addendum on Estimands and Sensitivity Analysis. 



Thank you for your request!
Our team will respond to you within 24 hours.